Evidence map›Paper›PMID 31658757›Full record

ReviewInternational journal of molecular sciences2019

Predicting Gonadal Germ Cell Cancer in People with Disorders of Sex Development; Insights from Developmental Biology.

Leendert H J Looijenga, Chia-Sui Kao, Muhammad T Idrees

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Guideline
  2. Meta-Analysis of Gene Expressions in Testicular Germ Cell Tumor Histologies.International journal of molecular sciences · 2020
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Complete androgen insensitivity syndrome: a case report and literature review.The Journal of international medical research · 2023
    Review
  12. Repetitive DNA Sequences in the Human Y Chromosome and Male Infertility.Frontiers in cell and developmental biology · 2022
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Complete Androgen Insensitivity Syndrome: From Bench to Bed.International journal of molecular sciences · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Leendert H J LooijengaProfessor Translational Patho-Oncology, Department of Pathology, Lab. for Experimental Patho-Oncology, Erasmus MC-University Medical Center Rotterdam, and Group Looijenga, Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands. l.looijenga@erasmusmc.nl.ORCID 0000-0002-8146-1911
Chia-Sui KaoDepartment of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA. ckao2@stanford.edu.
Muhammad T IdreesDepartment of Pathology, Indiana University School of Medicine, Indianapolis, IN 46202, USA. midrees@iupui.edu.
Erasmus MC · NLIndiana University School of MedicineStanford University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The risk of gonadal germ cell cancer (GGCC) is increased in selective subgroups, amongst others, defined patients with disorders of sex development (DSD). The increased risk is due to the presence of part of the Y chromosome, i.e., GonadoBlastoma on Y chromosome GBY region, as well as anatomical localization and degree of testicularization and maturation of the gonad. The latter specifically relates to the germ cells present being at risk when blocked in an embryonic stage of development. GGCC originates from either germ cell neoplasia in situ (testicular environment) or gonadoblastoma (ovarian-like environment). These precursors are characterized by presence of the markers OCT3/4 (POU5F1), SOX17, NANOG, as well as TSPY, and cKIT and its ligand KITLG. One of the aims is to stratify individuals with an increased risk based on other parameters than histological investigation of a gonadal biopsy. These might include evaluation of defined susceptibility alleles, as identified by Genome Wide Association Studies, and detailed evaluation of the molecular mechanism underlying the DSD in the individual patient, combined with DNA, mRNA, and microRNA profiling of liquid biopsies. This review will discuss the current opportunities as well as limitations of available knowledge in the context of predicting the risk of GGCC in individual patients.

Indexed as

AnimalsBiomarkers, TumorBiopsyCell Cycle ProteinsChromosomes, Human, YDevelopmental BiologyDisorders of Sex DevelopmentGenetic Predisposition to DiseaseGerm CellsGonadoblastomaGonadsHumansMaleNanog Homeobox ProteinNeoplasms, Germ Cell and EmbryonalOctamer Transcription Factor-3Biomarkers, TumorCell Cycle ProteinsNanog Homeobox ProteinNANOG protein, humanOctamer Transcription Factor-3POU5F1 protein, humanProto-Oncogene Proteins c-kitSOX17 protein, humanSOXF Transcription FactorsTSPY1 protein, humandevelopmental pathogenesisdisorders of sex developmentgerm cell cancerindividual risk assessmentprediction

Identifiers

PMID31658757
PMCPMC6834166
OpenAlexW2979660868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.